Physician profile
Bryan Trumm
NPI 1568610103
$18,226.16
in general payments reported to CMS, 2019-2025
14 companies · $398 in 2025
The $398 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,626 · 2020: $3,885 · 2021: $6,140 · 2022: $1,361 · 2023: $1,719 · 2024: $98.18 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,141 · Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,140.62 |
| Food and Beverage | $1,073.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,126.15 | 2019-2021 | |
| Wardlow Enterprises | $4,355.06 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $1,583.56 | 2019-2023 | Comprehensive Shoulder System |
| Depuy Synthes Sales INC. | $1,025.95 | 2020-2025 | Inhance, Velys, Attune |
| Ethicon INC. | $577.50 | 2020 | |
| Stryker Corporation | $246.16 | 2021-2025 | Gamma, Pangea, Inspace |
| Endo Pharmaceuticals INC. | $98.26 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $53.64 | 2025 | |
| Medical Device Business Services, INC. | $52.00 | 2021-2023 | Inhance |
| Smith+Nephew, INC. | $46.24 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $19.07 | 2025 | Iovera, Zilretta |
| Sanofi-Aventis U.S. LLC | $15.58 | 2019 | |
| Sanara Medtech INC. | $14.08 | 2023 | Celleraterx |
| Bioventus LLC | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Trumm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.